Nuo Therapeutics

About:

Nuo Therapeutics develops biological therapies to address the areas of wound care, inflammation, and angiogenesis.

Website: http://www.nuot.com/

Twitter/X: cytomedix

Top Investors: Deerfield, Deerfield Capital Management, Lincoln Park Capital Fund, Maryland Venture Fund

Description:

Nuo Therapeutics is a biotechnology company that develops, sells, and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation, and angiogenesis. The Company markets the AutoloGel System, a device for the production of platelet rich plasma gel derived from the patient's own blood. The AutoloGel System is cleared by the United States Food and Drug Administration for use on a variety of exuding wounds. Nuo Therapeutics is headquartered in Gaithersburg, Maryland.